357 related articles for article (PubMed ID: 11229606)
1. Effects of conventional and new peritoneal dialysis solutions on human peritoneal mesothelial cell viability and proliferation.
Ha H; Yu MR; Choi HN; Cha MK; Kang HS; Kim MH; Lee HB
Perit Dial Int; 2000; 20 Suppl 5():S10-8. PubMed ID: 11229606
[TBL] [Abstract][Full Text] [Related]
2. First in vitro and in vivo experiences with Stay-Safe Balance, a pH-neutral solution in a dual-chambered bag.
Lage C; Pischetsrieder M; Aufricht C; Jörres A; Schilling H; Passlick-Deetjen J
Perit Dial Int; 2000; 20 Suppl 5():S28-32. PubMed ID: 11229609
[TBL] [Abstract][Full Text] [Related]
3. Effects of peritoneal dialysis solutions on the secretion of growth factors and extracellular matrix proteins by human peritoneal mesothelial cells.
Ha H; Cha MK; Choi HN; Lee HB
Perit Dial Int; 2002; 22(2):171-7. PubMed ID: 11990400
[TBL] [Abstract][Full Text] [Related]
4. Newly Developed Neutralized pH Icodextrin Dialysis Fluid: Nonclinical Evaluation.
Yamaguchi N; Miyamoto K; Murata T; Ishikawa E; Horiuchi T
Artif Organs; 2016 Aug; 40(8):E158-66. PubMed ID: 27530675
[TBL] [Abstract][Full Text] [Related]
5. The in vitro biocompatibility performance of a 25 mmol/L bicarbonate/10 mmol/L lactate-buffered peritoneal dialysis fluid.
Skoufos L; Topley N; Cooker L; Dawnay A; Millar DJ; Holmes CJ; Faict D
Kidney Int Suppl; 2003 Dec; (88):S94-9. PubMed ID: 14870882
[TBL] [Abstract][Full Text] [Related]
6. Effect of two-chambered bicarbonate lactate-buffered peritoneal dialysis fluids on peripheral blood mononuclear cell and polymorphonuclear cell function in vitro.
Sundaram S; Cendoroglo M; Cooker LA; Jaber BL; Faict D; Holmes CJ; Pereira BJ
Am J Kidney Dis; 1997 Nov; 30(5):680-9. PubMed ID: 9370184
[TBL] [Abstract][Full Text] [Related]
7. Mesothelial toxicity of peritoneal dialysis fluids is related primarily to glucose degradation products, not to glucose per se.
Witowski J; Bender TO; Wisniewska-Elnur J; Ksiazek K; Passlick-Deetjen J; Breborowicz A; Jörres A
Perit Dial Int; 2003; 23(4):381-90. PubMed ID: 12968847
[TBL] [Abstract][Full Text] [Related]
8. Effects of bicarbonate/lactate solution on peritoneal advanced glycosylation end-product accumulation.
Park MS; Kim JK; Holmes C; Weiss MF
Perit Dial Int; 2000; 20 Suppl 5():S33-8. PubMed ID: 11229610
[TBL] [Abstract][Full Text] [Related]
9. Time to reconsider saline as the ideal rinsing solution during abdominal surgery.
Połubinska A; Winckiewicz M; Staniszewski R; Breborowicz A; Oreopoulos DG
Am J Surg; 2006 Sep; 192(3):281-5. PubMed ID: 16920418
[TBL] [Abstract][Full Text] [Related]
10. Biocompatibility of new peritoneal dialysis solutions: clinical experience.
Garcia-Lopez E; Lindholm B; Tranaeus A
Perit Dial Int; 2000; 20 Suppl 5():S48-56. PubMed ID: 11229612
[TBL] [Abstract][Full Text] [Related]
11. Osmotic agents and buffers in peritoneal dialysis solution: monocyte cytokine release and in vitro cytotoxicity.
Plum J; Schoenicke G; Grabensee B
Am J Kidney Dis; 1997 Sep; 30(3):413-22. PubMed ID: 9292571
[TBL] [Abstract][Full Text] [Related]
12. In vitro effects of bicarbonate and bicarbonate-lactate buffered peritoneal dialysis solutions on mesothelial and neutrophil function.
Topley N; Kaur D; Petersen MM; Jörres A; Williams JD; Faict D; Holmes CJ
J Am Soc Nephrol; 1996 Feb; 7(2):218-24. PubMed ID: 8785390
[TBL] [Abstract][Full Text] [Related]
13. Effect of bicarbonate/lactate peritoneal dialysis solutions on human mesothelial cell proliferation ex vivo.
Bajo MA; del Peso G; Castro MA; Díaz C; Castro MJ; Gil F; Sánchez-Tomero JA; Selgas R
Adv Perit Dial; 2001; 17():37-41. PubMed ID: 11510293
[TBL] [Abstract][Full Text] [Related]
14. Biocompatible dialysis fluids for peritoneal dialysis.
Cho Y; Johnson DW; Craig JC; Strippoli GF; Badve SV; Wiggins KJ
Cochrane Database Syst Rev; 2014 Mar; (3):CD007554. PubMed ID: 24671928
[TBL] [Abstract][Full Text] [Related]
15. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
[TBL] [Abstract][Full Text] [Related]
16. Reduced glucose degradation products in bicarbonate/lactate-buffered peritoneal dialysis solutions produced in two-chambered bags.
Cooker LA; Luneburg P; Faict D; Choo C; Holmes CJ
Perit Dial Int; 1997; 17(4):373-8. PubMed ID: 9284465
[TBL] [Abstract][Full Text] [Related]
17. Glucose degradation products and the peritoneal mesothelium.
Jörres A; Bender TO; Witowski J
Perit Dial Int; 2000; 20 Suppl 5():S19-22. PubMed ID: 11229607
[TBL] [Abstract][Full Text] [Related]
18. Biocompatibility of a bicarbonate/lactate-buffered PD fluid tested with a double-chamber cell culture system.
Fusshoeller A; Baehr J; Grabensee B; Plum J
Perit Dial Int; 2005; 25(4):387-93. PubMed ID: 16022097
[TBL] [Abstract][Full Text] [Related]
19. Comparison of icodextrin- and glucose-based peritoneal dialysis fluids in their acute and chronic effects on human peritoneal mesothelial cells.
Bender TO; Witowski J; Ksiazek K; Jörres A
Int J Artif Organs; 2007 Dec; 30(12):1075-82. PubMed ID: 18203069
[TBL] [Abstract][Full Text] [Related]
20. Glucose degradation products (GDP) retard remesothelialization independently of D-glucose concentration.
Morgan LW; Wieslander A; Davies M; Horiuchi T; Ohta Y; Beavis MJ; Craig KJ; Williams JD; Topley N
Kidney Int; 2003 Nov; 64(5):1854-66. PubMed ID: 14531821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
